Medindia

X

Nepalese Researchers Identify New Treatment for Drug-resistant Typhoid

by VR Sreeraman on  June 27, 2007 at 5:44 PM Drug News   - G J E 4
Nepalese Researchers Identify New Treatment for Drug-resistant Typhoid
Nepalese researchers have established that the affordable drug, Gatifloxacin, is a better treatment for drug- resistant typhoid.

The study was conducted by a team of researchers led by Dr Buddha Basnyat at Patan Hospital Lalitpur in Kathmandu, Nepal.
Advertisement

As part of the study, researchers compared the effect of the new drug with Cefixime, which is currently recommended by the World Health Organisation for treating enteric fever.

Advertisement
Researchers found that the new cost-effective fluoroquinolone drug, might be better than Cefixime.

"The currently recommended treatment, Cefixime, is relatively expensive and must be administered for a longer duration than is ideal. Clearly there is an urgent need for a treatment that is cost-effective and easy to administer," Basnyat said.

The study also noted that Salmonella enterica Typhi and Salmonella enterica serovar Paratyhpi A, the two most common bacteria to cause enteric fever, do not show resistance to Gatifloxacin, unlike for other fluoroquinolones.

The findings of the study were published in journal PLoS ONE.

Source: ANI
SRM/M
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: